Evaluate the safety and effectiveness of iSTAR Medical's MINIject™ implant for lowering intraocular pressure (IOP) in subjects with primary open-angle glaucoma.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Intraocular pressure decrease
Timeframe: 24 months
Intraocular pressure decrease (outcome 2)
Timeframe: 24 months